Xingyun Su

548 total citations
20 papers, 401 citations indexed

About

Xingyun Su is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Xingyun Su has authored 20 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Oncology. Recurrent topics in Xingyun Su's work include Thyroid Cancer Diagnosis and Treatment (9 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and BRCA gene mutations in cancer (2 papers). Xingyun Su is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (9 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and BRCA gene mutations in cancer (2 papers). Xingyun Su collaborates with scholars based in China, United States and Madagascar. Xingyun Su's co-authors include Lisong Teng, Weibin Wang, Xin Xu, Xiaodong Teng, Thomas J. Fahey, Jiang Cao, Haiyong Wang, Xiaoxia Jiang, Zhonghai Guan and Yongfeng Ding and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Cancer.

In The Last Decade

Xingyun Su

18 papers receiving 397 citations

Peers

Xingyun Su
Celina Montemayor United States
Bangbo Zhao China
Concetta Sciammarella Italy
Ana Serrano-Somavilla Spain
Hanna Zielińska Poland
Britta Heinze Germany
Arnon Arazi United States
Petia Mitchell United States
Ilenia Chatziandreou Greece
Helen Ding United States
Celina Montemayor United States
Xingyun Su
Citations per year, relative to Xingyun Su Xingyun Su (= 1×) peers Celina Montemayor

Countries citing papers authored by Xingyun Su

Since Specialization
Citations

This map shows the geographic impact of Xingyun Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingyun Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingyun Su more than expected).

Fields of papers citing papers by Xingyun Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingyun Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingyun Su. The network helps show where Xingyun Su may publish in the future.

Co-authorship network of co-authors of Xingyun Su

This figure shows the co-authorship network connecting the top 25 collaborators of Xingyun Su. A scholar is included among the top collaborators of Xingyun Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingyun Su. Xingyun Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xiuming, Jiangshan Lian, Xingyun Su, et al.. (2025). Artificial liver support systems bridge severe immune-mediated hepatotoxicity to clinical recovery. Immunopharmacology and Immunotoxicology. 47(2). 194–200.
2.
3.
Chen, Zhendong, Xingyun Su, Weipu Zhu, et al.. (2024). Preoperative Serum Lipids as Novel Predictors of Survival in 3575 Patients With Papillary Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 110(3). 668–676. 2 indexed citations
4.
Wang, Yue, Xingyun Su, Yurong Zhao, et al.. (2023). BRAFV600E restructures cellular lactylation to promote anaplastic thyroid cancer proliferation. Endocrine Related Cancer. 30(8). 47 indexed citations
5.
6.
Wang, Weibin, Xingyun Su, Yongfeng Ding, et al.. (2022). Preoperative Thyroid Peroxidase Antibody Predicts Recurrence in Papillary Thyroid Carcinoma: A Consecutive Study With 5,770 Cases. Frontiers in Oncology. 12. 881024–881024. 4 indexed citations
7.
8.
Wang, Weibin, Xingyun Su, Yongfeng Ding, et al.. (2021). Thyroid Function Abnormalities in COVID-19 Patients. Frontiers in Endocrinology. 11. 623792–623792. 61 indexed citations
9.
Su, Xingyun, Xiaoxia Jiang, Tuo Zhang, et al.. (2020). VCAM-1 Upregulation Contributes to Insensitivity of Vemurafenib in BRAF-Mutant Thyroid Cancer. Translational Oncology. 13(2). 441–451. 12 indexed citations
10.
Su, Xingyun, Kuifeng He, Jie Zhou, et al.. (2019). Clonal analysis of early-stage bilateral papillary thyroid cancer identifies field cancerization. Endocrine. 64(3). 614–621. 5 indexed citations
11.
Ding, Yongfeng, Xingyun Su, Linrong Li, et al.. (2019). Nomogram-Based New Recurrence Predicting System in Early-Stage Papillary Thyroid Cancer. International Journal of Endocrinology. 2019. 1–7. 12 indexed citations
12.
Jiang, Xiaoxia, Xin Xu, Mengjie Wu, et al.. (2018). GPRC5A: An Emerging Biomarker in Human Cancer. BioMed Research International. 2018. 1–11. 30 indexed citations
13.
Teng, Lisong, Xingyun Su, Xiaoxia Jiang, et al.. (2016). Diagnostic value of BRAFV600E-mutation analysis in fine-needle aspiration of thyroid nodules: a meta-analysis. OncoTargets and Therapy. 9. 2495–2495. 29 indexed citations
14.
Su, Xingyun, Xiaoxia Jiang, Weibin Wang, et al.. (2016). Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis. OncoTargets and Therapy. Volume 9. 6965–6976. 24 indexed citations
15.
Zheng, Lingyan, Cong Xu, Zhonghai Guan, et al.. (2016). Galectin-1 mediates TGF-β-induced transformation from normal fibroblasts into carcinoma-associated fibroblasts and promotes tumor progression in gastric cancer.. PubMed. 8(4). 1641–58. 30 indexed citations
16.
Su, Xingyun, Weibin Wang, Min Liang, et al.. (2016). A Comprehensive Characterization of Mitochondrial Genome in Papillary Thyroid Cancer. International Journal of Molecular Sciences. 17(10). 1594–1594. 24 indexed citations
17.
Xu, Xin, Xingyun Su, Kuifeng He, et al.. (2015). Establishment and characterization of GCSR1, a multi-drug resistant signet ring cell gastric cancer cell line. International Journal of Oncology. 46(6). 2479–2487. 8 indexed citations
18.
19.
Su, Xingyun, et al.. (2014). ER-α36: a novel biomarker and potential therapeutic target in breast cancer. SHILAP Revista de lepidopterología. 7 indexed citations
20.
Teng, Lisong, Xingyun Su, Xin Xu, et al.. (2014). ER-α36: a novel biomarker and potential therapeutic target in breast cancer. OncoTargets and Therapy. 7. 1525–1525. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Celina Montemayor Breakdown of academic impact, for papers by Bangbo Zhao Breakdown of academic impact, for papers by Concetta Sciammarella Breakdown of academic impact, for papers by Ana Serrano-Somavilla Breakdown of academic impact, for papers by Hanna Zielińska Breakdown of academic impact, for papers by Britta Heinze Breakdown of academic impact, for papers by Arnon Arazi Breakdown of academic impact, for papers by Petia Mitchell Breakdown of academic impact, for papers by Ilenia Chatziandreou Breakdown of academic impact, for papers by Helen Ding
Rankless by CCL
2026